NDC 52686-221

SHISEIDO Future LX Day/Jour

Ensulizole, Octinoxate And Octocrylene

SHISEIDO Future LX Day/Jour is a Topical Cream in the Human Otc Drug category. It is labeled and distributed by Shiseido America Inc.. The primary component is Ensulizole; Octinoxate; Octocrylene.

Product ID52686-221_cfb1b58a-f158-4159-8659-c6cd46bf9560
NDC52686-221
Product TypeHuman Otc Drug
Proprietary NameSHISEIDO Future LX Day/Jour
Generic NameEnsulizole, Octinoxate And Octocrylene
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2009-09-01
Marketing CategoryOTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
Application Numberpart352
Labeler NameSHISEIDO AMERICA INC.
Substance NameENSULIZOLE; OCTINOXATE; OCTOCRYLENE
Active Ingredient Strength1 g/51g; g/51g; g/51g
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 52686-221-50

1 JAR in 1 BOX (52686-221-50) > 51 g in 1 JAR
Marketing Start Date2009-09-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 52686-221-50 [52686022150]

SHISEIDO Future LX Day/Jour CREAM
Marketing CategoryOTC monograph not final
Application Numberpart352
Product TypeHUMAN OTC DRUG
Marketing Start Date2009-09-01
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
ENSULIZOLE1.02 g/51g

OpenFDA Data

SPL SET ID:81be179f-0952-4198-a526-a4762d15ca34
Manufacturer
UNII

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.